Biopharma Business

Tag "cancer immunotherapy"

NIH launches $215m partnership for cancer immunotherapy strategies

    NIH launches $215m partnership for cancer immunotherapy strategies

The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot… The National Institutes of Health (NIH)

Read Full Article

Successor to PD-1 inhibitors the focus of cancer immunotherapy

    Successor to PD-1 inhibitors the focus of cancer immunotherapy

The cancer immunotherapy pipeline, displays a high level of first-in-class innovation with novel developments focusing heavily on producing the next big immune checkpoint inhibitor, according to GBI Research. GBI Research’s

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements